InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,489.20
(
0.23%
)
Post# of 427
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

flatlander_60048

Send PM Follow Ignore
Followers 10
Posts 476
Boards Moderated 0
Alias Born 02/10/2006

flatlander_60048

Re: DewDiligence post# 165

Thursday, 01/26/2012 9:52:22 AM

Thursday, January 26, 2012 9:52:22 AM

Post# of 427
I'm inclined to agree the more some of the facts get released. However, it is obvious to me that NVS's competitors and there investors are more than happy to try to slow Gilenya's uptake by claiming it has a bad risk benefit profile.

During an investor conference about a year ago Bill Marth from Teva indicated that Laquinimod would have a much better safety profile than Gilenya. He forgot to mention that the efficacy would be about half that of Gilenya. I think that Biogen and Sanofi supporters are more than happy to get negative Gilenya stories out in the media even if it has questionable merits. Hopefully the reviews progress quickly.

FL

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NVS News
More NVS News
InvestorsHub NewsWire

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM

Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM

Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM

IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM

Start posting your company's news
Only $200 per official company press release!